EMEA (Europe, Middle East and Africa) Adalimumab Biosimilar Market Report 2017

October 2017 | 111 pages | ID: E91BBB78520EN
QYResearch

Abstracts

In this report, the EMEA Adalimumab Biosimilar market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Units), revenue (Million USD), market share and growth rate of Adalimumab Biosimilar for these regions, from 2012 to 2022 (forecast)

• Europe: Germany, France, UK, Russia, Italy and Benelux;
• Middle East: Saudi Arabia, Israel, UAE and Iran;
• Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Adalimumab Biosimilar market competition by top manufacturers/players, with Adalimumab Biosimilar sales volume (K Units), price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including

• AET BioTech
• Amgen
• Boehringer Ingelheim
• Coherus Biosciences
• Fujifilm Kyowa Kirin Biologics
• LG Life Sciences/Mochida Pharmaceutical
• Momenta Pharmaceuticals
• Oncobiologics
• Pfizer
• Samsung Bioepsis
• Sandoz
• Zydus Cadila

On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into

• Tablet
• Oral Solution

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Units), market share and growth rate of Adalimumab Biosimilar for each application, including

• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

EMEA (Europe, Middle East and Africa) Adalimumab Biosimilar Market Report 2017

1 ADALIMUMAB BIOSIMILAR OVERVIEW

1.1 Product Overview and Scope of Adalimumab Biosimilar
1.2 Classification of Adalimumab Biosimilar
  1.2.1 EMEA Adalimumab Biosimilar Market Size (Sales) Comparison by Type (2012-2022)
  1.2.2 EMEA Adalimumab Biosimilar Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 Tablet
  1.2.4 Oral Solution
1.3 EMEA Adalimumab Biosimilar Market by Application/End Users
  1.3.1 EMEA Adalimumab Biosimilar Sales (Volume) and Market Share Comparison by Application (2012-2022
  1.3.2 Hospital Pharmacy
  1.3.3 Retail Pharmacy
  1.3.4 Online Pharmacy
1.4 EMEA Adalimumab Biosimilar Market by Region
  1.4.1 EMEA Adalimumab Biosimilar Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 Europe Status and Prospect (2012-2022)
  1.4.3 Middle East Status and Prospect (2012-2022)
  1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of Adalimumab Biosimilar (2012-2022)
  1.5.1 EMEA Adalimumab Biosimilar Sales and Growth Rate (2012-2022)
  1.5.2 EMEA Adalimumab Biosimilar Revenue and Growth Rate (2012-2022)

2 EMEA ADALIMUMAB BIOSIMILAR COMPETITION BY MANUFACTURERS/PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 EMEA Adalimumab Biosimilar Market Competition by Players/Manufacturers
  2.1.1 EMEA Adalimumab Biosimilar Sales Volume and Market Share of Major Players (2012-2017)
  2.1.2 EMEA Adalimumab Biosimilar Revenue and Share by Players (2012-2017)
  2.1.3 EMEA Adalimumab Biosimilar Sale Price by Players (2012-2017)
2.2 EMEA Adalimumab Biosimilar (Volume and Value) by Type/Product Category
  2.2.1 EMEA Adalimumab Biosimilar Sales and Market Share by Type (2012-2017)
  2.2.2 EMEA Adalimumab Biosimilar Revenue and Market Share by Type (2012-2017)
  2.2.3 EMEA Adalimumab Biosimilar Sale Price by Type (2012-2017)
2.3 EMEA Adalimumab Biosimilar (Volume) by Application
2.4 EMEA Adalimumab Biosimilar (Volume and Value) by Region
  2.4.1 EMEA Adalimumab Biosimilar Sales and Market Share by Region (2012-2017)
  2.4.2 EMEA Adalimumab Biosimilar Revenue and Market Share by Region (2012-2017)
  2.4.3 EMEA Adalimumab Biosimilar Sales Price by Region (2012-2017)

3 EUROPE ADALIMUMAB BIOSIMILAR (VOLUME, VALUE AND SALES PRICE), BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

3.1 Europe Adalimumab Biosimilar Sales and Value (2012-2017)
  3.1.1 Europe Adalimumab Biosimilar Sales Volume and Growth Rate (2012-2017)
  3.1.2 Europe Adalimumab Biosimilar Revenue and Growth Rate (2012-2017)
3.2 Europe Adalimumab Biosimilar Sales and Market Share by Type
3.3 Europe Adalimumab Biosimilar Sales and Market Share by Application
3.4 Europe Adalimumab Biosimilar Sales Volume and Value (Revenue) by Countries
  3.4.1 Europe Adalimumab Biosimilar Sales Volume by Countries (2012-2017)
  3.4.2 Europe Adalimumab Biosimilar Revenue by Countries (2012-2017)
  3.4.3 Germany Adalimumab Biosimilar Sales and Growth Rate (2012-2017)
  3.4.4 France Adalimumab Biosimilar Sales and Growth Rate (2012-2017)
  3.4.5 UK Adalimumab Biosimilar Sales and Growth Rate (2012-2017)
  3.4.6 Russia Adalimumab Biosimilar Sales and Growth Rate (2012-2017)
  3.4.7 Italy Adalimumab Biosimilar Sales and Growth Rate (2012-2017)
  3.4.8 Benelux Adalimumab Biosimilar Sales and Growth Rate (2012-2017)

4 MIDDLE EAST ADALIMUMAB BIOSIMILAR (VOLUME, VALUE AND SALES PRICE), BY REGION, TYPE AND APPLICATION

4.1 Middle East Adalimumab Biosimilar Sales and Value (2012-2017)
  4.1.1 Middle East Adalimumab Biosimilar Sales Volume and Growth Rate (2012-2017)
  4.1.2 Middle East Adalimumab Biosimilar Revenue and Growth Rate (2012-2017)
4.2 Middle East Adalimumab Biosimilar Sales and Market Share by Type
4.3 Middle East Adalimumab Biosimilar Sales and Market Share by Application
4.4 Middle East Adalimumab Biosimilar Sales Volume and Value (Revenue) by Countries
  4.4.1 Middle East Adalimumab Biosimilar Sales Volume by Countries (2012-2017)
  4.4.2 Middle East Adalimumab Biosimilar Revenue by Countries (2012-2017)
  4.4.3 Saudi Arabia Adalimumab Biosimilar Sales and Growth Rate (2012-2017)
  4.4.4 Israel Adalimumab Biosimilar Sales and Growth Rate (2012-2017)
  4.4.5 UAE Adalimumab Biosimilar Sales and Growth Rate (2012-2017)
  4.4.6 Iran Adalimumab Biosimilar Sales and Growth Rate (2012-2017)

5 AFRICA ADALIMUMAB BIOSIMILAR (VOLUME, VALUE AND SALES PRICE) BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

5.1 Africa Adalimumab Biosimilar Sales and Value (2012-2017)
  5.1.1 Africa Adalimumab Biosimilar Sales Volume and Growth Rate (2012-2017)
  5.1.2 Africa Adalimumab Biosimilar Revenue and Growth Rate (2012-2017)
5.2 Africa Adalimumab Biosimilar Sales and Market Share by Type
5.3 Africa Adalimumab Biosimilar Sales and Market Share by Application
5.4 Africa Adalimumab Biosimilar Sales Volume and Value (Revenue) by Countries
  5.4.1 Africa Adalimumab Biosimilar Sales Volume by Countries (2012-2017)
  5.4.2 Africa Adalimumab Biosimilar Revenue by Countries (2012-2017)
  5.4.3 South Africa Adalimumab Biosimilar Sales and Growth Rate (2012-2017)
  5.4.4 Nigeria Adalimumab Biosimilar Sales and Growth Rate (2012-2017)
  5.4.5 Egypt Adalimumab Biosimilar Sales and Growth Rate (2012-2017)
  5.4.6 Algeria Adalimumab Biosimilar Sales and Growth Rate (2012-2017)

6 EMEA ADALIMUMAB BIOSIMILAR MANUFACTURERS/PLAYERS PROFILES AND SALES DATA

6.1 AET BioTech
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Adalimumab Biosimilar Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 AET BioTech Adalimumab Biosimilar Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Amgen
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Adalimumab Biosimilar Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Amgen Adalimumab Biosimilar Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Boehringer Ingelheim
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Adalimumab Biosimilar Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Boehringer Ingelheim Adalimumab Biosimilar Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Coherus Biosciences
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Adalimumab Biosimilar Product Type, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Coherus Biosciences Adalimumab Biosimilar Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Fujifilm Kyowa Kirin Biologics
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Adalimumab Biosimilar Product Type, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Fujifilm Kyowa Kirin Biologics Adalimumab Biosimilar Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 LG Life Sciences/Mochida Pharmaceutical
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Adalimumab Biosimilar Product Type, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 LG Life Sciences/Mochida Pharmaceutical Adalimumab Biosimilar Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Momenta Pharmaceuticals
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Adalimumab Biosimilar Product Type, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Momenta Pharmaceuticals Adalimumab Biosimilar Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Oncobiologics
  6.8.1 Company Basic Information, Manufacturing Base and Competitors
  6.8.2 Adalimumab Biosimilar Product Type, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Oncobiologics Adalimumab Biosimilar Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Pfizer
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 Adalimumab Biosimilar Product Type, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Pfizer Adalimumab Biosimilar Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Samsung Bioepsis
  6.10.1 Company Basic Information, Manufacturing Base and Competitors
  6.10.2 Adalimumab Biosimilar Product Type, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Samsung Bioepsis Adalimumab Biosimilar Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview
6.11 Sandoz
6.12 Zydus Cadila

7 ADALIMUMAB BIOSIMILAR MANUFACTURING COST ANALYSIS

7.1 Adalimumab Biosimilar Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Adalimumab Biosimilar

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Adalimumab Biosimilar Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Adalimumab Biosimilar Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA ADALIMUMAB BIOSIMILAR MARKET FORECAST (2017-2022)

11.1 EMEA Adalimumab Biosimilar Sales, Revenue and Price Forecast (2017-2022)
  11.1.1 EMEA Adalimumab Biosimilar Sales and Growth Rate Forecast (2017-2022)
  11.1.2 EMEA Adalimumab Biosimilar Revenue and Growth Rate Forecast (2017-2022)
  11.1.3 EMEA Adalimumab Biosimilar Price and Trend Forecast (2017-2022)
11.2 EMEA Adalimumab Biosimilar Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe Adalimumab Biosimilar Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt Adalimumab Biosimilar Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa Adalimumab Biosimilar Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA Adalimumab Biosimilar Sales Forecast by Type (2017-2022)
11.7 EMEA Adalimumab Biosimilar Sales Forecast by Application (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Adalimumab Biosimilar
Figure EMEA Adalimumab Biosimilar Sales Volume (K Units) by Type (2012-2022)
Figure EMEA Adalimumab Biosimilar Sales Volume Market Share by Type (Product Category) in 2016
Figure Tablet Product Picture
Figure Oral Solution Product Picture
Figure EMEA Adalimumab Biosimilar Sales Volume (K Units) by Application (2012-2022)
Figure EMEA Sales Market Share of Adalimumab Biosimilar by Application in 2016
Figure Hospital Pharmacy Examples
Table Key Downstream Customer in Hospital Pharmacy
Figure Retail Pharmacy Examples
Table Key Downstream Customer in Retail Pharmacy
Figure Online Pharmacy Examples
Table Key Downstream Customer in Online Pharmacy
Figure EMEA Adalimumab Biosimilar Market Size (Million USD) by Region (2012-2022)
Figure Europe Adalimumab Biosimilar Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Adalimumab Biosimilar Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Adalimumab Biosimilar Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Adalimumab Biosimilar Revenue (Million USD) Status and Forecast by Countries
Figure Africa Adalimumab Biosimilar Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Adalimumab Biosimilar Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Adalimumab Biosimilar Sales Volume and Growth Rate (2012-2022)
Figure EMEA Adalimumab Biosimilar Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA Adalimumab Biosimilar Market Major Players Product Sales Volume (K Units) (2012-2017)
Table EMEA Adalimumab Biosimilar Sales Volume (K Units) of Major Players (2012-2017)
Table EMEA Adalimumab Biosimilar Sales Share by Players (2012-2017)
Figure 2016 Adalimumab Biosimilar Sales Share by Players
Figure 2017 Adalimumab Biosimilar Sales Share by Players
Figure EMEA Adalimumab Biosimilar Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA Adalimumab Biosimilar Revenue (Million USD) by Players (2012-2017)
Table EMEA Adalimumab Biosimilar Revenue Share by Players (2012-2017)
Table 2016 EMEA Adalimumab Biosimilar Revenue Share by Players
Table 2017 EMEA Adalimumab Biosimilar Revenue Share by Players
Table EMEA Adalimumab Biosimilar Sale Price (USD/Unit) by Players (2012-2017)
Table EMEA Adalimumab Biosimilar Sales (K Units) and Market Share by Type (2012-2017)
Table EMEA Adalimumab Biosimilar Sales Share by Type (2012-2017)
Figure Sales Market Share of Adalimumab Biosimilar by Type (2012-2017)
Figure EMEA Adalimumab Biosimilar Sales Market Share by Type (2012-2017)
Table EMEA Adalimumab Biosimilar Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA Adalimumab Biosimilar Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Adalimumab Biosimilar by Type in 2016
Table EMEA Adalimumab Biosimilar Sale Price (USD/Unit) by Type (2012-2017)
Table EMEA Adalimumab Biosimilar Sales (K Units) and Market Share by Application (2012-2017)
Table EMEA Adalimumab Biosimilar Sales Share by Application (2012-2017)
Figure Sales Market Share of Adalimumab Biosimilar by Application (2012-2017)
Figure EMEA Adalimumab Biosimilar Sales Market Share by Application in 2016
Table EMEA Adalimumab Biosimilar Sales (K Units) and Market Share by Region (2012-2017)
Table EMEA Adalimumab Biosimilar Sales Share by Region (2012-2017)
Figure Sales Market Share of Adalimumab Biosimilar by Region (2012-2017)
Figure EMEA Adalimumab Biosimilar Sales Market Share in 2016
Table EMEA Adalimumab Biosimilar Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA Adalimumab Biosimilar Revenue Share by Region (2012-2017)
Figure Revenue Market Share of Adalimumab Biosimilar by Region (2012-2017)
Figure EMEA Adalimumab Biosimilar Revenue Market Share Regions in 2016
Table EMEA Adalimumab Biosimilar Sales Price (USD/Unit) by Region (2012-2017)
Figure Europe Adalimumab Biosimilar Sales (K Units) and Growth Rate (2012-2017)
Figure Europe Adalimumab Biosimilar Revenue and Growth Rate (2012-2017)
Table Europe Adalimumab Biosimilar Sales (K Units) by Type (2012-2017)
Table Europe Adalimumab Biosimilar Market Share by Type (2012-2017)
Figure Europe Adalimumab Biosimilar Market Share by Type in 2016
Table Europe Adalimumab Biosimilar Sales (K Units) by Application (2012-2017)
Table Europe Adalimumab Biosimilar Market Share by Application (2012-2017)
Figure Europe Adalimumab Biosimilar Market Share by Application in 2016
Table Europe Adalimumab Biosimilar Sales (K Units) by Countries (2012-2017)
Table Europe Adalimumab Biosimilar Sales Market Share by Countries (2012-2017)
Figure Europe Adalimumab Biosimilar Sales Market Share by Countries (2012-2017)
Figure Europe Adalimumab Biosimilar Sales Market Share by Countries in 2016
Table Europe Adalimumab Biosimilar Revenue (Million USD) by Countries (2012-2017)
Table Europe Adalimumab Biosimilar Revenue Market Share by Countries (2012-2017)
Figure Europe Adalimumab Biosimilar Revenue Market Share by Countries (2012-2017)
Figure Europe Adalimumab Biosimilar Revenue Market Share by Countries in 2016
Figure Germany Adalimumab Biosimilar Sales (K Units) and Growth Rate (2012-2017)
Figure France Adalimumab Biosimilar Sales (K Units) and Growth Rate (2012-2017)
Figure UK Adalimumab Biosimilar Sales (K Units) and Growth Rate (2012-2017)
Figure Russia Adalimumab Biosimilar Sales (K Units) and Growth Rate (2012-2017)
Figure Italy Adalimumab Biosimilar Sales (K Units) and Growth Rate (2012-2017)
Figure Benelux Adalimumab Biosimilar Sales (K Units) and Growth Rate (2012-2017)
Figure Middle East Adalimumab Biosimilar Sales (K Units) and Growth Rate (2012-2017)
Figure Middle East Adalimumab Biosimilar Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East Adalimumab Biosimilar Sales (K Units) by Type (2012-2017)
Table Middle East Adalimumab Biosimilar Market Share by Type (2012-2017)
Figure Middle East Adalimumab Biosimilar Market Share by Type (2012-2017)
Table Middle East Adalimumab Biosimilar Sales (K Units) by Applications (2012-2017)
Table Middle East Adalimumab Biosimilar Market Share by Applications (2012-2017)
Figure Middle East Adalimumab Biosimilar Sales Market Share by Application in 2016
Table Middle East Adalimumab Biosimilar Sales Volume (K Units) by Countries (2012-2017)
Table Middle East Adalimumab Biosimilar Sales Volume Market Share by Countries (2012-2017)
Figure Middle East Adalimumab Biosimilar Sales Volume Market Share by Countries in 2016
Table Middle East Adalimumab Biosimilar Revenue (Million USD) by Countries (2012-2017)
Table Middle East Adalimumab Biosimilar Revenue Market Share by Countries (2012-2017)
Figure Middle East Adalimumab Biosimilar Revenue Market Share by Countries (2012-2017)
Figure Middle East Adalimumab Biosimilar Revenue Market Share by Countries in 2016
Figure Saudi Arabia Adalimumab Biosimilar Sales (K Units) and Growth Rate (2012-2017)
Figure Israel Adalimumab Biosimilar Sales (K Units) and Growth Rate (2012-2017)
Figure UAE Adalimumab Biosimilar Sales (K Units) and Growth Rate (2012-2017)
Figure Iran Adalimumab Biosimilar Sales (K Units) and Growth Rate (2012-2017)
Figure Africa Adalimumab Biosimilar Sales (K Units) and Growth Rate (2012-2017)
Figure Africa Adalimumab Biosimilar Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa Adalimumab Biosimilar Sales (K Units) by Type (2012-2017)
Table Africa Adalimumab Biosimilar Sales Market Share by Type (2012-2017)
Figure Africa Adalimumab Biosimilar Sales Market Share by Type (2012-2017)
Figure Africa Adalimumab Biosimilar Sales Market Share by Type in 2016
Table Africa Adalimumab Biosimilar Sales (K Units) by Application (2012-2017)
Table Africa Adalimumab Biosimilar Sales Market Share by Application (2012-2017)
Figure Africa Adalimumab Biosimilar Sales Market Share by Application (2012-2017)
Table Africa Adalimumab Biosimilar Sales Volume (K Units) by Countries (2012-2017)
Table Africa Adalimumab Biosimilar Sales Market Share by Countries (2012-2017)
Figure Africa Adalimumab Biosimilar Sales Market Share by Countries (2012-2017)
Figure Africa Adalimumab Biosimilar Sales Market Share by Countries in 2016
Table Africa Adalimumab Biosimilar Revenue (Million USD) by Countries (2012-2017)
Table Africa Adalimumab Biosimilar Revenue Market Share by Countries (2012-2017)
Figure Africa Adalimumab Biosimilar Revenue Market Share by Countries (2012-2017)
Figure Africa Adalimumab Biosimilar Revenue Market Share by Countries in 2016
Figure South Africa Adalimumab Biosimilar Sales (K Units) and Growth Rate (2012-2017)
Figure Nigeria Adalimumab Biosimilar Sales (K Units) and Growth Rate (2012-2017)
Figure Egypt Adalimumab Biosimilar Sales (K Units) and Growth Rate (2012-2017)
Figure Algeria Adalimumab Biosimilar Sales (K Units) and Growth Rate (2012-2017)
Table AET BioTech Adalimumab Biosimilar Basic Information List
Table AET BioTech Adalimumab Biosimilar Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure AET BioTech Adalimumab Biosimilar Sales (K Units) and Growth Rate (2012-2017)
Figure AET BioTech Adalimumab Biosimilar Sales Market Share in EMEA (2012-2017)
Figure AET BioTech Adalimumab Biosimilar Revenue Market Share in EMEA (2012-2017)
Table Amgen Adalimumab Biosimilar Basic Information List
Table Amgen Adalimumab Biosimilar Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Amgen Adalimumab Biosimilar Sales (K Units) and Growth Rate (2012-2017)
Figure Amgen Adalimumab Biosimilar Sales Market Share in EMEA (2012-2017)
Figure Amgen Adalimumab Biosimilar Revenue Market Share in EMEA (2012-2017)
Table Boehringer Ingelheim Adalimumab Biosimilar Basic Information List
Table Boehringer Ingelheim Adalimumab Biosimilar Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Boehringer Ingelheim Adalimumab Biosimilar Sales (K Units) and Growth Rate (2012-2017)
Figure Boehringer Ingelheim Adalimumab Biosimilar Sales Market Share in EMEA (2012-2017)
Figure Boehringer Ingelheim Adalimumab Biosimilar Revenue Market Share in EMEA (2012-2017)
Table Coherus Biosciences Adalimumab Biosimilar Basic Information List
Table Coherus Biosciences Adalimumab Biosimilar Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Coherus Biosciences Adalimumab Biosimilar Sales (K Units) and Growth Rate (2012-2017)
Figure Coherus Biosciences Adalimumab Biosimilar Sales Market Share in EMEA (2012-2017)
Figure Coherus Biosciences Adalimumab Biosimilar Revenue Market Share in EMEA (2012-2017)
Table Fujifilm Kyowa Kirin Biologics Adalimumab Biosimilar Basic Information List
Table Fujifilm Kyowa Kirin Biologics Adalimumab Biosimilar Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Fujifilm Kyowa Kirin Biologics Adalimumab Biosimilar Sales (K Units) and Growth Rate (2012-2017)
Figure Fujifilm Kyowa Kirin Biologics Adalimumab Biosimilar Sales Market Share in EMEA (2012-2017)
Figure Fujifilm Kyowa Kirin Biologics Adalimumab Biosimilar Revenue Market Share in EMEA (2012-2017)
Table LG Life Sciences/Mochida Pharmaceutical Adalimumab Biosimilar Basic Information List
Table LG Life Sciences/Mochida Pharmaceutical Adalimumab Biosimilar Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure LG Life Sciences/Mochida Pharmaceutical Adalimumab Biosimilar Sales (K Units) and Growth Rate (2012-2017)
Figure LG Life Sciences/Mochida Pharmaceutical Adalimumab Biosimilar Sales Market Share in EMEA (2012-2017)
Figure LG Life Sciences/Mochida Pharmaceutical Adalimumab Biosimilar Revenue Market Share in EMEA (2012-2017)
Table Momenta Pharmaceuticals Adalimumab Biosimilar Basic Information List
Table Momenta Pharmaceuticals Adalimumab Biosimilar Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Momenta Pharmaceuticals Adalimumab Biosimilar Sales (K Units) and Growth Rate (2012-2017)
Figure Momenta Pharmaceuticals Adalimumab Biosimilar Sales Market Share in EMEA (2012-2017)
Figure Momenta Pharmaceuticals Adalimumab Biosimilar Revenue Market Share in EMEA (2012-2017)
Table Oncobiologics Adalimumab Biosimilar Basic Information List
Table Oncobiologics Adalimumab Biosimilar Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Oncobiologics Adalimumab Biosimilar Sales (K Units) and Growth Rate (2012-2017)
Figure Oncobiologics Adalimumab Biosimilar Sales Market Share in EMEA (2012-2017)
Figure Oncobiologics Adalimumab Biosimilar Revenue Market Share in EMEA (2012-2017)
Table Pfizer Adalimumab Biosimilar Basic Information List
Table Pfizer Adalimumab Biosimilar Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Pfizer Adalimumab Biosimilar Sales (K Units) and Growth Rate (2012-2017)
Figure Pfizer Adalimumab Biosimilar Sales Market Share in EMEA (2012-2017)
Figure Pfizer Adalimumab Biosimilar Revenue Market Share in EMEA (2012-2017)
Table Samsung Bioepsis Adalimumab Biosimilar Basic Information List
Table Samsung Bioepsis Adalimumab Biosimilar Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Samsung Bioepsis Adalimumab Biosimilar Sales (K Units) and Growth Rate (2012-2017)
Figure Samsung Bioepsis Adalimumab Biosimilar Sales Market Share in EMEA (2012-2017)
Figure Samsung Bioepsis Adalimumab Biosimilar Revenue Market Share in EMEA (2012-2017)
Table Sandoz Adalimumab Biosimilar Basic Information List
Table Zydus Cadila Adalimumab Biosimilar Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Adalimumab Biosimilar
Figure Manufacturing Process Analysis of Adalimumab Biosimilar
Figure Adalimumab Biosimilar Industrial Chain Analysis
Table Raw Materials Sources of Adalimumab Biosimilar Major Manufacturers in 2016
Table Major Buyers of Adalimumab Biosimilar
Table Distributors/Traders List
Figure EMEA Adalimumab Biosimilar Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure EMEA Adalimumab Biosimilar Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA Adalimumab Biosimilar Price (USD/Unit) and Trend Forecast (2017-2022)
Table EMEA Adalimumab Biosimilar Sales (K Units) Forecast by Region (2017-2022)
Figure EMEA Adalimumab Biosimilar Sales Market Share Forecast by Region (2017-2022)
Table EMEA Adalimumab Biosimilar Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA Adalimumab Biosimilar Revenue Market Share Forecast by Region (2017-2022)
Table Europe Adalimumab Biosimilar Sales (K Units) Forecast by Countries (2017-2022)
Figure Europe Adalimumab Biosimilar Sales Market Share Forecast by Countries (2017-2022)
Table Europe Adalimumab Biosimilar Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Adalimumab Biosimilar Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Adalimumab Biosimilar Sales (K Units) Forecast by Countries (2017-2022)
Figure Middle East Adalimumab Biosimilar Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Adalimumab Biosimilar Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East Adalimumab Biosimilar Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Adalimumab Biosimilar Sales (K Units) Forecast by Countries (2017-2022)
Figure Africa Adalimumab Biosimilar Sales Market Share Forecast by Countries (2017-2022)
Table Africa Adalimumab Biosimilar Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa Adalimumab Biosimilar Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Adalimumab Biosimilar Sales (K Units) Forecast by Type (2017-2022)
Figure EMEA Adalimumab Biosimilar Sales Market Share Forecast by Type (2017-2022)
Table EMEA Adalimumab Biosimilar Sales (K Units) Forecast by Application (2017-2022)
Figure EMEA Adalimumab Biosimilar Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources